Cargando…

Impact of prone positioning duration on the outcome of patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A meta-analysis

PURPOSE: Research has shown that prone positioning (PP) improves the survival of patients receiving venovenous extracorporeal membrane oxygenation (V–V ECMO) for acute respiratory distress syndrome (ARDS). However, the reported impact of PP duration on the outcome of V–V ECMO patients with ARDS vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Huai, Jiaping, Ye, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764689/
https://www.ncbi.nlm.nih.gov/pubmed/36568680
http://dx.doi.org/10.1016/j.heliyon.2022.e12320
Descripción
Sumario:PURPOSE: Research has shown that prone positioning (PP) improves the survival of patients receiving venovenous extracorporeal membrane oxygenation (V–V ECMO) for acute respiratory distress syndrome (ARDS). However, the reported impact of PP duration on the outcome of V–V ECMO patients with ARDS varies across studies. METHODS: A meta-analysis approach was used to identify studies that investigated the impact of PP duration on the outcome of ARDS patients who were treated with V–V ECMO; the following databases were used: MEDLINE, Embase, Wanfang, and the China National Knowledge Infrastructure. The primary outcome was cumulative survival. Secondary outcomes were length of stay in an intensive care unit, exchange of arterial blood gases, and adverse events. RESULTS: A total of 8 studies were included in the final meta-analysis. Patients with longer duration of PP (≥12 h) had a longer survival period (risk ratio: 1.24; 95% confidence interval: 1.00, 1.54]) than those with PP < 12 h. There was no evidence of publication bias across the studies. CONCLUSION: Our results imply that a longer duration of PP ≥ 12 h might improve the outcome of patients with ARDS who receive V–V ECMO therapy.